Water Island Capital LLC Clearside Biomedical, Inc. Transaction History

Water Island Capital LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2024	BUY	$0.82 - $1.27 $8,200 - $12,700	10,000 Added 13.79%	82,500 $71,000
Q3 2023 Nov 14, 2023	BUY	$0.82 - $1.27 $8,200 - $12,700	10,000 Added 13.79%	82,500 $72,000
Q2 2023 Nov 14, 2024	BUY	$0.97 - $1.48 $7,275 - $11,100	7,500 Added 11.54%	72,500 $81,000
Q2 2023 Aug 14, 2023	BUY	$0.97 - $1.48 $7,275 - $11,100	7,500 Added 11.54%	72,500 $81,000
Q1 2023 Nov 14, 2024	BUY	$0.93 - $1.66 $16,740 - $29,880	18,000 Added 38.3%	65,000 $67,000
Q1 2023 May 25, 2023	BUY	$0.93 - $1.66 $16,740 - $29,880	18,000 Added 38.3%	65,000 $68,000
Q4 2022 Nov 14, 2024	BUY	$1.0 - $1.5 $47,000 - $70,500	47,000 New	47,000 $52,000
Q4 2022 Feb 14, 2023	BUY	$1.0 - $1.5 $47,000 - $70,500	47,000 New	47,000 $53,000

12.2M

54.7K

50.7K

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $56M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Water Island Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Water Island Capital LLC with notifications on news.